231 related articles for article (PubMed ID: 25748131)
1. [Topics of neuromyelitis optica].
Miyamoto K
Nihon Rinsho Meneki Gakkai Kaishi; 2014; 37(6):468-74. PubMed ID: 25748131
[TBL] [Abstract][Full Text] [Related]
2. Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.
Kitley J; Waters P; Woodhall M; Leite MI; Murchison A; George J; Küker W; Chandratre S; Vincent A; Palace J
JAMA Neurol; 2014 Mar; 71(3):276-83. PubMed ID: 24425068
[TBL] [Abstract][Full Text] [Related]
3. Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica.
Rostásy K; Mader S; Hennes EM; Schanda K; Gredler V; Guenther A; Blaschek A; Korenke C; Pritsch M; Pohl D; Maier O; Kuchukhidze G; Brunner-Krainz M; Berger T; Reindl M
Mult Scler; 2013 Jul; 19(8):1052-9. PubMed ID: 23257621
[TBL] [Abstract][Full Text] [Related]
4. Change in autoantibody and cytokine responses during the evolution of neuromyelitis optica in patients with systemic lupus erythematosus: A preliminary study.
Kovacs KT; Kalluri SR; Boza-Serrano A; Deierborg T; Csepany T; Simo M; Rokusz L; Miseta A; Alcaraz N; Czirjak L; Berki T; Molnar T; Hemmer B; Illes Z
Mult Scler; 2016 Aug; 22(9):1192-201. PubMed ID: 26514978
[TBL] [Abstract][Full Text] [Related]
5. Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype.
Kitley J; Woodhall M; Waters P; Leite MI; Devenney E; Craig J; Palace J; Vincent A
Neurology; 2012 Sep; 79(12):1273-7. PubMed ID: 22914827
[TBL] [Abstract][Full Text] [Related]
6. [Neuromyelitis optica in children. Two case reports].
Tosello B; Halbert C; Mancini J; Chabrol B; Boucraut J; Milh M
Arch Pediatr; 2012 Aug; 19(8):827-31. PubMed ID: 22789744
[TBL] [Abstract][Full Text] [Related]
7. [Neuromyelitis optica].
Kvistad SA; Wergeland S; Torkildsen Ø; Myhr KM; Vedeler CA
Tidsskr Nor Laegeforen; 2013 Oct; 133(19):2057-61. PubMed ID: 24129537
[TBL] [Abstract][Full Text] [Related]
8. [Neuromyelitis optica and anti-aquaporin 4 antibody--distinct from multiple sclerosis].
Misu T; Takahashi T; Nakashima I; Fujihara K; Itoyama Y
Rinsho Byori; 2009 Mar; 57(3):262-70. PubMed ID: 19363997
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers for neuromyelitis optica.
Chang KH; Ro LS; Lyu RK; Chen CM
Clin Chim Acta; 2015 Feb; 440():64-71. PubMed ID: 25444748
[TBL] [Abstract][Full Text] [Related]
10. Clinical spectrum of CNS aquaporin-4 autoimmunity.
Kim SH; Kim W; Li XF; Jung IJ; Kim HJ
Neurology; 2012 Apr; 78(15):1179-85. PubMed ID: 22459676
[TBL] [Abstract][Full Text] [Related]
11. Neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein antibody-associated disease: current topics.
Fujihara K; Cook LJ
Curr Opin Neurol; 2020 Jun; 33(3):300-308. PubMed ID: 32374571
[TBL] [Abstract][Full Text] [Related]
12. [Treatment and clinical management of patients with neuromyelitis optica and anti-aquaporin 4 antibody].
Ochi H
Brain Nerve; 2010 Sep; 62(9):945-52. PubMed ID: 20844305
[TBL] [Abstract][Full Text] [Related]
13. Neuromyelitis optica and aquaporin-4 (AQP4) autoantibodies in consecutive optic neuritis patients in Southern Finland.
Siuko M; Tienari PJ; Saastamoinen KP; Atula S; Miettinen A; Kivelä T; Setälä K
Acta Ophthalmol; 2014 Jun; 92(4):387-91. PubMed ID: 23773223
[TBL] [Abstract][Full Text] [Related]
14. [Current Status and Prospects of Complement-Targeting Therapy for Neuromyelitis Optica].
Kuroda H; Fujihara K
Brain Nerve; 2019 Jun; 71(6):573-580. PubMed ID: 31171754
[TBL] [Abstract][Full Text] [Related]
15. Neuromyelitis optica (NMO) antibody positivity in patients with transverse myelitis and no visual manifestations.
Hamnik SE; Hacein-Bey L; Biller J; Gruener G; Jay W
Semin Ophthalmol; 2008; 23(3):191-200. PubMed ID: 18432545
[TBL] [Abstract][Full Text] [Related]
16. [European treatment recommendation of neuromyelitis optica spectrum disorders: critical remarks and case discussion].
Kőszegi E; Illés Z
Ideggyogy Sz; 2012 May; 65(5-6):201-6. PubMed ID: 22724289
[TBL] [Abstract][Full Text] [Related]
17. [Diagnostic criteria and differential diagnosis of neuromyelitis optica].
Nakashima I
Nihon Rinsho; 2014 Nov; 72(11):1964-9. PubMed ID: 25518378
[TBL] [Abstract][Full Text] [Related]
18. Neuromyelitis optica: an update.
Matà S; Lolli F
J Neurol Sci; 2011 Apr; 303(1-2):13-21. PubMed ID: 21300379
[TBL] [Abstract][Full Text] [Related]
19. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre.
Takahashi T; Fujihara K; Nakashima I; Misu T; Miyazawa I; Nakamura M; Watanabe S; Shiga Y; Kanaoka C; Fujimori J; Sato S; Itoyama Y
Brain; 2007 May; 130(Pt 5):1235-43. PubMed ID: 17449477
[TBL] [Abstract][Full Text] [Related]
20. [Anti-MOG + neuromyelitis optica spectrum disorders treated with plasmapheresis].
Oshiro A; Nakamura S; Tamashiro K; Fujihara K
No To Hattatsu; 2016 May; 48(3):199-203. PubMed ID: 27349083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
